This study demonstrates that AI-based chatbots should not be evaluated in a clinical context using a single 'best practice' approach. For public health-critical diseases such as brucellosis, selective and controlled chatbot integration tailored to the intended use may offer a safer and more effective approach.
Çetinkaya et al. (Fri,) studied this question.